6869.T
The company maintains a strong liquidity position, with a current ratio of 2.97 and cash and equivalents amounting to 89.57 billion JPY. Its debt-to-equity ratio is 0.14, indicating a conservative capital structure with limited leverage. The company's price-to-book ratio is 1.87, and its price-to-tangible-book ratio is also 1.87, suggesting that the market values the company's tangible assets at a premium relative to its book value. In terms of profitability, the company's return on equity (ROE) is 11.57%, and its return on assets (ROA) is 8.07%, both of which are strong indicators of efficient capital utilization and asset management. The company's operating income of 87.06 billion JPY and net income of 53.67 billion JPY reflect a healthy margin structure, with a gross profit of 271.98 billion JPY on total revenue of 508.64 billion JPY. The company's revenue is concentrated in the healthcare services and equipment industry, with no disclosed geographic diversification or segment breakdown provided in the available data. This lack of segmentation makes it difficult to assess the geographic or product-specific exposure of the company's revenue. Looking ahead, the company is projected to maintain a stable growth trajectory, with no specific numeric deltas provided in the outlook. However, the company's operating cash flow of 88.25 billion JPY and free cash flow of 24.20 billion JPY suggest a solid cash generation capability, which supports ongoing operations and potential reinvestment. The company's risk profile is characterized by low liquidity and dilution risks, with no immediate filing-based liquidity or dilution flags detected. The dilution potential is also low, and the company has not made any recent equity issuances or disclosed any dilutive events in the available data. Recent events, including filings and transcripts, have not been disclosed in the available data. Analysts have provided a mean price target of 1,859.33 JPY and a median price target of 1,650.00 JPY, with a mean recommendation of 2.41, indicating a generally positive outlook from the investment community.
Business. The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.
Classification. The company is classified under the industry "Medical Equipment, Supplies & Distribution" within the business sector "Healthcare Services & Equipment," with a classification confidence of 0.92.
- The company has a strong liquidity position with a current ratio of 2.97 and significant cash reserves.
- The company's ROE of 11.57% and ROA of 8.07% indicate efficient capital and asset utilization.
- The company's conservative capital structure, with a debt-to-equity ratio of 0.14, suggests limited financial risk.
- Analysts have a generally positive outlook, with a mean price target of 1,859.33 JPY and a median price target of 1,650.00 JPY.
- --
- # RATIONALES
- ```json
- {
- No immediate filing-based liquidity or dilution flags were detected.